Regulation of human pregnane X receptor and its target gene cytochrome P450 3A4 by Chinese herbal compounds and a molecular docking study

The pregnane X receptor (PXR) plays a critical role in the regulation of human cytochrome P450 3A4 (CYP3A4) gene. In this study, we investigated the effect of an array of compounds isolated from Chinese herbal medicines on the activity of PXR using a luciferase reporter gene assay in transiently transfected HepG2 and Huh7 cells and on the expression of PXR and CYP3A4 in LS174T cells. Furthermore, molecular docking was performed to investigate the binding modes of herbal compounds with PXR. Praeruptorin A and C, salvianolic acid B, sodium danshensu, protocatechuic aldehyde, cryptotanshinone, emodin, morin, and tanshinone IIA significantly transactivated the CYP3A4 reporter gene construct in either HepG2 or Huh7 cells. The PXR mRNA expression in LS174T cells was significantly induced by physcion, protocatechuic aldehyde, salvianolic acid B, and sodium danshensu. However, epifriedelanol, morin, praeruptorin D, mulberroside A, tanshinone I, and tanshinone IIA significantly down-regulated the expression of PXR mRNA in LS174T cells. All the herbal compounds tested can be readily docked into the ligand-binding cavity of PXR mainly through hydrogen bond and aromatic interactions with Ser247, Gln285, His407, and Arg401. These findings suggest that herbal medicines can significantly regulate PXR and CYP3A4 and this has important implication in herb–drug interactions.

[1]  M. Stoner,et al.  Rational quantitative structure-activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands. , 2010, Chemico-biological interactions.

[2]  G. Rajaraman,et al.  Human Pregnane X Receptor Agonism by Ginkgo biloba Extract: Assessment of the Role of Individual Ginkgolides , 2010, Journal of Pharmacology and Experimental Therapeutics.

[3]  M. Ingelman-Sundberg,et al.  CYP3A4 Catalytic Activity Is Induced in Confluent Huh7 Hepatoma Cells , 2010, Drug Metabolism and Disposition.

[4]  M. Eichelbaum,et al.  Regulation of CYP3A4 by pregnane X receptor: The role of nuclear receptors competing for response element binding. , 2010, Biochemical and biophysical research communications.

[5]  S. Strom,et al.  Genetic Predictors of Interindividual Variability in Hepatic CYP3A4 Expression , 2010, Journal of Pharmacology and Experimental Therapeutics.

[6]  Z. Dvořák,et al.  Intestinal cell-specific vitamin D receptor (VDR)-mediated transcriptional regulation of CYP3A4 gene. , 2010, Biochemical pharmacology.

[7]  J. Pascussi,et al.  Pregnane × Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation , 2010, Molecular Cancer.

[8]  Dima Kozakov,et al.  The structural basis of pregnane X receptor binding promiscuity. , 2009, Biochemistry.

[9]  Sean Ekins,et al.  Challenges Predicting Ligand-Receptor Interactions of Promiscuous Proteins: The Nuclear Receptor PXR , 2009, PLoS Comput. Biol..

[10]  Shufeng Zhou,et al.  Polymorphism of human cytochrome P450 enzymes and its clinical impact , 2009, Drug metabolism reviews.

[11]  K. Yoshinari,et al.  Unveiling a New Essential Cis Element for the Transactivation of the CYP3A4 Gene by Xenobiotics , 2009, Molecular Pharmacology.

[12]  J. Chen,et al.  Preferential Physical and Functional Interaction of Pregnane X Receptor with the SMRTα Isoform , 2009, Molecular Pharmacology.

[13]  M. Negishi,et al.  Nuclear Xenobiotic Receptor Pregnane X Receptor Locks Corepressor Silencing Mediator for Retinoid and Thyroid Hormone Receptors (SMRT) onto the CYP24A1 Promoter to Attenuate Vitamin D3 Activation , 2009, Molecular Pharmacology.

[14]  S. Zeng,et al.  PXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA. , 2009, Chemico-biological interactions.

[15]  X. Chu,et al.  Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytes , 2009, Nucleic acids research.

[16]  T. Guo,et al.  Regulation of gene expression of hepatic drug metabolizing enzymes and transporters by the Toll-like receptor 2 ligand, lipoteichoic acid. , 2009, Archives of biochemistry and biophysics.

[17]  Bruce Blumberg,et al.  Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells , 2009, BMC Cancer.

[18]  E. McCarthy,et al.  Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions. , 2008, Journal of alternative and complementary medicine.

[19]  T. Sueyoshi,et al.  Identification of Ginkgo biloba as a Novel Activator of Pregnane X Receptor , 2008, Drug Metabolism and Disposition.

[20]  Kristin Lichti-Kaiser,et al.  The Traditional Chinese Herbal Remedy Tian Xian Activates Pregnane X Receptor and Induces CYP3A Gene Expression in Hepatocytes , 2008, Drug Metabolism and Disposition.

[21]  S. Mani,et al.  Synthesis of novel ketoconazole derivatives as inhibitors of the human Pregnane X Receptor (PXR; NR1I2; also termed SXR, PAR). , 2008, Bioorganic & medicinal chemistry letters.

[22]  Sean Ekins,et al.  Machine learning methods and docking for predicting human pregnane X receptor activation. , 2008, Chemical research in toxicology.

[23]  Shufeng Zhou.  Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. , 2008, Current drug metabolism.

[24]  D. Buckley,et al.  Role of Human Pregnane X Receptor in Tamoxifen- and 4-Hydroxytamoxifen-Mediated CYP3A4 Induction in Primary Human Hepatocytes and LS174T Cells , 2008, Drug Metabolism and Disposition.

[25]  Z. Dvořák,et al.  Azole Antimycotics Differentially Affect Rifampicin-Induced Pregnane X Receptor-Mediated CYP3A4 Gene Expression , 2008, Drug Metabolism and Disposition.

[26]  J. Waring,et al.  Trovafloxacin-Induced Gene Expression Changes in Liver-Derived in Vitro Systems: Comparison of Primary Human Hepatocytes to HepG2 Cellss⃞ , 2008, Drug Metabolism and Disposition.

[27]  Fu-jun Liu,et al.  The far and distal enhancers in the CYP3A4 gene co-ordinate the proximal promoter in responding similarly to the pregnane X receptor but differentially to hepatocyte nuclear factor-4alpha. , 2008, The Biochemical journal.

[28]  Magnus Ingelman-Sundberg,et al.  Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. , 2007, Pharmacology & therapeutics.

[29]  Sean Ekins,et al.  Human Pregnane X Receptor Antagonists and Agonists Define Molecular Requirements for Different Binding Sites , 2007, Molecular Pharmacology.

[30]  J. Hakkola,et al.  Transcription Factor Binding to a Putative Double E-Box Motif Represses CYP3A4 Expression in Human Lung Cells , 2007, Molecular Pharmacology.

[31]  Leslie M. Tompkins,et al.  Mechanisms of cytochrome P450 induction , 2007, Journal of biochemical and molecular toxicology.

[32]  Ilya Raskin,et al.  Revisiting the ancient concept of botanical therapeutics. , 2007, Nature chemical biology.

[33]  Z. Dvořák,et al.  Valproic Acid Induces CYP3A4 and MDR1 Gene Expression by Activation of Constitutive Androstane Receptor and Pregnane X Receptor Pathways , 2007, Drug Metabolism and Disposition.

[34]  S. Strom,et al.  Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. , 2007, Toxicology and applied pharmacology.

[35]  M. Eichelbaum,et al.  Molecular Mechanism of Basal CYP3A4 Regulation by Hepatocyte Nuclear Factor 4α: Evidence for Direct Regulation in the Intestine , 2007, Drug Metabolism and Disposition.

[36]  L. Moore,et al.  Crystal structure of the pregnane X receptor-estradiol complex provides insights into endobiotic recognition. , 2007, Molecular endocrinology.

[37]  Shi-hong Zhang,et al.  Dan Shen agents for acute ischaemic stroke. , 2007, The Cochrane database of systematic reviews.

[38]  M. Negishi,et al.  CAR and PXR: The xenobiotic-sensing receptors , 2007, Steroids.

[39]  R. Evers,et al.  Attenuating pregnane X receptor (PXR) activation: A molecular modelling approach , 2007, Xenobiotica; the fate of foreign compounds in biological systems.

[40]  C. Martinez-Jimenez,et al.  Transcriptional regulation and expression of CYP3A4 in hepatocytes. , 2007, Current drug metabolism.

[41]  Denise G. Teotico,et al.  Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole , 2007, Oncogene.

[42]  Y. Z. Chen,et al.  In Silico Prediction of Pregnane X Receptor Activators by Machine Learning Approache , 2007, Molecular Pharmacology.

[43]  B. Blumberg,et al.  The Dietary Isothiocyanate Sulforaphane Is an Antagonist of the Human Steroid and Xenobiotic Nuclear Receptor , 2007, Molecular Pharmacology.

[44]  C. Smith,et al.  Differential Regulation of Hepatic CYP2B6 and CYP3A4 Genes by Constitutive Androstane Receptor but Not Pregnane X Receptor , 2006, Journal of Pharmacology and Experimental Therapeutics.

[45]  Mary F Paine,et al.  THE HUMAN INTESTINAL CYTOCHROME P450 “PIE” , 2006, Drug Metabolism and Disposition.

[46]  W. Welsh,et al.  Structural Model Reveals Key Interactions in the Assembly of the Pregnane X Receptor/Corepressor Complex , 2006, Molecular Pharmacology.

[47]  Ruei-Ming Chen,et al.  Induction of cytochrome P450‐dependent monooxygenase by extracts of the medicinal herb Salvia miltiorrhiza , 2006, The Journal of pharmacy and pharmacology.

[48]  T. Nikolskaya,et al.  A COMBINED APPROACH TO DRUG METABOLISM AND TOXICITY ASSESSMENT , 2006, Drug Metabolism and Disposition.

[49]  A. Baum,et al.  Traditional Chinese Medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) Activate Pregnane X Receptor and Increase Warfarin Clearance in Rats , 2006, Journal of Pharmacology and Experimental Therapeutics.

[50]  J. C. Ghosh,et al.  Regulation and Binding of Pregnane X Receptor by Nuclear Receptor Corepressor Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) , 2006, Molecular Pharmacology.

[51]  Zhong Zuo,et al.  Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use , 2005, Journal of clinical pharmacology.

[52]  Oliver Burk,et al.  Antimalarial Artemisinin Drugs Induce Cytochrome P450 and MDR1 Expression by Activation of Xenosensors Pregnane X Receptor and Constitutive Androstane Receptor , 2005, Molecular Pharmacology.

[53]  L. Moore,et al.  Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin. , 2005, Molecular endocrinology.

[54]  Thierry Langer,et al.  The Identification of Ligand Features Essential for PXR Activation by Pharmacophore Modeling , 2005, J. Chem. Inf. Model..

[55]  Y. Hashimoto,et al.  The effects of culture conditions on CYP3A4 and MDR1 mRNA induction by 1alpha,25-dihydroxyvitamin D(3) in human intestinal cell lines, Caco-2 and LS180. , 2005, Drug metabolism and pharmacokinetics.

[56]  Wei Duan,et al.  Herb-drug interactions: a literature review. , 2005, Drugs.

[57]  W. Humphreys,et al.  CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development. , 2004, Current drug metabolism.

[58]  Sean Ekins,et al.  PXR and the regulation of apoA1 and HDL-cholesterol in rodents. , 2004, Pharmacological research.

[59]  B. Goodwin,et al.  Guggulsterone Activates Multiple Nuclear Receptors and Induces CYP3A Gene Expression through the Pregnane X Receptor , 2004, Journal of Pharmacology and Experimental Therapeutics.

[60]  Jose Cosme,et al.  Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone , 2004, Science.

[61]  Angela J Harris,et al.  Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells. , 2004, Mutation research.

[62]  H. Yamazaki,et al.  Identification of a novel polymorphic enhancer of the human CYP3A4 gene. , 2004, Molecular pharmacology.

[63]  Sean Ekins,et al.  A Ligand-Based Approach to Understanding Selectivity of Nuclear Hormone Receptors PXR, CAR, FXR, LXRα, and LXRβ , 2002, Pharmaceutical Research.

[64]  E Ernst,et al.  Herbal medicines put into context , 2003, BMJ : British Medical Journal.

[65]  Charles L. Brooks,et al.  Detailed analysis of grid‐based molecular docking: A case study of CDOCKER—A CHARMm‐based MD docking algorithm , 2003, J. Comput. Chem..

[66]  M. Lambert,et al.  Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. , 2003, Journal of molecular biology.

[67]  L. Moore,et al.  2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. , 2003, Biochemistry.

[68]  D. Russell,et al.  Clinical importance of the cytochromes P450 , 2002, The Lancet.

[69]  A. Takeshita,et al.  Putative Role of the Orphan Nuclear Receptor SXR (Steroid and Xenobiotic Receptor) in the Mechanism of CYP3A4 Inhibition by Xenobiotics* , 2002, The Journal of Biological Chemistry.

[70]  B. Goodwin,et al.  Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. , 2002, Molecular pharmacology.

[71]  N. Plant,et al.  Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[72]  R. Edwards,et al.  Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[73]  Sean Ekins,et al.  A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta. , 2002, Pharmaceutical research.

[74]  Sean Ekins,et al.  A pharmacophore for human pregnane X receptor ligands. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[75]  J. Hudson,et al.  The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. , 2001, Pharmacogenetics.

[76]  L. Moore,et al.  The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity , 2001, Science.

[77]  B. M. Forman,et al.  The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux , 2001, Nature Medicine.

[78]  A. Y. Lu,et al.  Interindividual variability in inhibition and induction of cytochrome P450 enzymes. , 2001, Annual review of pharmacology and toxicology.

[79]  B. Neuschwander‐Tetri,et al.  Humanized xenobiotic response in mice expressing nuclear receptor SXR , 2000, Nature.

[80]  L. Moore,et al.  St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Adriane Fugh-Berman,et al.  Herb-drug interactions , 2000, The Lancet.

[82]  B. Goodwin,et al.  The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. , 1999, Molecular pharmacology.

[83]  F. Guengerich,et al.  Cytochrome P-450 3A4: regulation and role in drug metabolism. , 1999, Annual review of pharmacology and toxicology.

[84]  R Ohlsson,et al.  Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[85]  J. Lehmann,et al.  The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. , 1998, The Journal of clinical investigation.

[86]  J. Lehmann,et al.  An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway , 1998, Cell.

[87]  Charles L. Brooks,et al.  Assessing energy functions for flexible docking , 1998, J. Comput. Chem..

[88]  P. Watkins,et al.  Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3. , 1997, Molecular pharmacology.

[89]  R. Tukey,et al.  Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes. , 1996, Molecular pharmacology.

[90]  S. Tagawa,et al.  Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control. , 1993, European journal of biochemistry.